Most Recent Articles by Lauren Biscaldi
Researchers sought to examine the most efficacious treatment for clinical remission in adults with schizophrenia.
In an 8-week open-label extension, escitalopram plus ziprasidone was found to be safe in certain patients, requiring regular cardiovascular and metabolic monitoring.
Data from 80 veterans with PTSD were studied to examine the biological pathways between PTSD and markers of cardiometabolic risk.
Patients with type 2 diabetes showed decreased negative health outcomes with annual depression screening.
Schizophrenia outpatients were examined in this 52-week open-label extension trial.
More Articles by Lauren Biscaldi
Psychiatry Advisor Articles
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Anxiety Prevention Interventions: How Effective Are They?
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Hypertension Linked to an Increased Risk of Dementia?
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- Maternal Glucocorticoid Exposure Not Associated With ADHD in Offspring
- Ketamine Not Associated With PTSD Development in Military Trauma Setting
- Content, Quality Issues for Both Paper-Based and Electronic Health Records